Global Medical REIT (GMRE) has shared an announcement.
At the 2024 Annual Meeting, shareholders decisively voted in favor of electing seven director nominees, approving executive compensation, and endorsing annual advisory votes on executive pay. Additionally, they approved a significant amendment to the equity incentive plan, increasing the reserve of shares by 1.5 million, and ratified the appointment of Deloitte & Touche LLP as the independent auditor for the year, marking a clear direction for the company’s governance and compensation strategies.
Learn more about GMRE stock on TipRanks’ Stock Analysis page.
